DOCSLIB.ORG

Tuning the System with Micrornas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tuning the System with Micrornas The cellular response to hypoxia: tuning the system with microRNAs Joseph Loscalzo J Clin Invest. 2010;120(11):3815-3817. https://doi.org/10.1172/JCI45105. Commentary Adaptation to hypoxia is an essential cellular response controlled by the oxygen-sensitive master transcription factor hypoxia-inducible factor 1 (HIF-1). HIF-1 expression is also controlled by specific microRNAs and, in turn, controls the expression of other microRNAs, which fine-tune adaptation to low oxygen tension. In this issue of the JCI, Ghosh and colleagues identify a unique microRNA in hypoxic endothelial cells, miR424, that promotes HIF-1 stabilization and angiogenesis. The actions of this microRNA are considered in the context of the complex interactions that act to ensure optimal endothelial adaptation to this critical environmental condition. Find the latest version: https://jci.me/45105/pdf commentaries gen molecules on human granulocytes during early overcoming immune barriers by stimulating stem 7. Luna G, Paez J, Cardier JE. Expression of the phases of differentiation. Proc Natl Acad Sci U S A. cell differentiation. Biol Blood Marrow Transplant. hematopoietic stem cell antigen Sca-1 (LY-6A/E) 1977;74(9):4012–4016. 2007;13(10):1135–1144. in liver sinusoidal endothelial cells: possible func- 3. Guba SC, Stella G, Turka LA, June CH, Thompson 5. Essers MA, et al. IFNalpha activates dormant tion of Sca-1 in endothelial cells. Stem Cells Dev. CB, Emerson SG. Regulation of interleukin 3 gene haematopoietic stem cells in vivo. Nature. 2009; 2004;13(5):528–535. induction in normal human T cells. J Clin Invest. 458(7240):904–908. 8. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Zheng P. 1989;84(6):1701–1706. 6. Baldridge MT, King KY, Boles NC, Weksberg DC, TSC-mTOR maintains quiescence and function of 4. Hexner EO, et al. Umbilical cord blood xeno- Goodell MA. Quiescent haematopoietic stem cells hematopoietic stem cells by repressing mitochon- grafts in immunodeficient mice reveal that T are activated by IFN-gamma in response to chronic drial biogenesis and reactive oxygen species. J Exp cells enhance hematopoietic engraftment beyond infection. Nature. 2010;465(7299):793–797. Med. 2008;205(10):2397–2408. The cellular response to hypoxia: tuning the system with microRNAs Joseph Loscalzo Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA. Adaptation to hypoxia is an essential cellular response controlled by the oxy- translation, enhance mRNA degradation, gen-sensitive master transcription factor hypoxia-inducible factor 1 (HIF-1). or both. In contrast to the promoter-based HIF-1 expression is also controlled by specific microRNAs and, in turn, catalytic amplification of mRNA synthesis, controls the expression of other microRNAs, which fine-tune adaptation to miRNAs are viewed as weak modulators of low oxygen tension. In this issue of the JCI, Ghosh and colleagues identify a the transcriptional response, fine-tuning unique microRNA in hypoxic endothelial cells, miR424, that promotes HIF-1 gene expression largely by negative regula- stabilization and angiogenesis. The actions of this microRNA are consid- tion in a process that requires stoichiometric ered in the context of the complex interactions that act to ensure optimal binding to mRNA targets (5). endothelial adaptation to this critical environmental condition. Hypoxamirs: microRNAs Adaptation to hypoxia is an essential hypoxic conditions, however, the α subunit induced by hypoxia homeostatic mechanism in mammalian does not undergo prolyl hydroxylation and, Hypoxia has recently been shown to induce cells. Hypoxia can occur not only as a global as a result, forms a stable complex with the the expression of a number of miRNAs, consequence of low atmospheric oxygen ten- β subunit, which binds as a heterodimer to which have been termed “hypoxamirs” (6). sion, but also locally at sites of inflamma- hypoxia response elements (HREs) in the Owing to the central importance of HIFs to tion, tissue ischemia and injury, and solid promoter regions of hypoxia-sensitive genes the hypoxic response, its potent regulation tumor growth. Fundamental mechanisms to induce gene transcription. HIF-depen- of many genes whose expression is regulated have, therefore, evolved by which cells adapt dent transcriptional changes lead to a broad by oxygen tension, and the significant num- to hypoxic conditions and their potentially range of cellular adaptations, including met- ber of hypoxamirs, it is logical to explore the adverse consequences, both acutely and abolic, proliferative, apoptotic, and angio- relationships among HIFs and hypoxamirs in chronically, in health and disease. genic. In higher metazoans, three different order to understand better the complex regu- Among the key responses to acute hypox- HIF-α proteins have been identified: HIF-1α lation of the hypoxic program in metazoans. ia is the upregulation of hypoxia-inducible and HIF-2α have some transcriptional tar- From the perspective of the miRNA factors (HIFs), master transcription factors gets in common and some that are unique to response to hypoxia, miRNAs can be viewed that induce the highly conserved expres- each subunit, while splice variants of HIF-3α as comprising three groups (Table 1): first, sion of many genes (likely more than 100) have dominant negative effects on HIF- those induced by HIFs under hypoxic con- and are responsible for the majority of the dependent gene transcription (2, 3). ditions (HIF-dependent hypoxamirs); sec- hypoxic program in metazoan cells (1). The ond, those induced by hypoxia that, in turn, prototypical HIF is a heterodimer of α and MicroRNAs and transcriptional affect expression of HIF; third, those whose β subunits. Under normoxic conditions, the tuning expression is not dependent on hypoxia but α subunit is rapidly hydroxylated at specific MicroRNA molecules (miRNAs) are essential, that affect HIF expression. The number of prolyl residues by prolyl hydroxylase domain noncanonical RNA species of 18–23 nucleo- hypoxamirs that have been identified in (PHD) proteins. Upon hydroxylation, the α tides in length that regulate gene expression. each of these groups is expanding rapidly, subunit is recognized by the von Hippel– There are believed to be more than 1,000 illustrating the extraordinary regulatory Lindau protein and consequently under- miRNA genes in the human genome, which complexity of the hypoxic program and the goes rapid proteasomal degradation. Under are estimated to regulate more than one- importance of considering that program in third of all mRNA transcripts (4). As part of a holistic, system-based context. In this issue the RNA-induced silencing complex (RISC), of the JCI, Ghosh and colleagues (7) identify Conflict of interest: The author has declared that no conflict of interest exists. miRNAs negatively regulate gene transcrip- a new hypoxamir, miR424, that affects HIF Citation for this article: J Clin Invest. 2010; tion by annealing to the 3′ untranslated expression. This report is unique for three 120(11):3815–3817. doi:10.1172/JCI45105. region of specific mRNA targets to repress reasons: it is the first demonstration of the The Journal of Clinical Investigation http://www.jci.org Volume 120 Number 11 November 2010 3815 commentaries Table 1 and limit ROS-mediated cytotoxicity. In this Hypoxia, microRNAs, and HIF way, miR424 is an important regulator of the durability of the hypoxic HIF program. Hypoxamirs induced by HIF Hypoxamirs that affect HIF miRNAs that affect HIF In addition and importantly, miR424 is independent of hypoxia induced by another potent transcription fac- miR210 miR20b miR107 tor, PU.1, levels of which increase in hypoxic miR373 miR199a miR17-92 cluster endothelium (7). This transcription factor miR424 miR31 working in concert with miR424 has been miR519c shown to regulate monocyte differentiation (24); miR424 has also been shown to regu- late monocyte differentiation by combinato- rial interactions with miR155, miR222, and hypoxic induction of this microRNA, as a by stabilizing HIF-α isoforms by impairing miR503 (25). Whether miR424 also regulates prior study showed that hypoxia suppressed their prolyl hydroxylation (7). miR424 itself endothelial cell differentiation from precur- its expression in trophoblasts (8); it is the is induced by hypoxia via PU.1 transactiva- sor cells is an unanswered question that first demonstration of a hypoxamir unique tion, levels of which are increased in hypoxic would add another dimension to the action to the endothelial cell; and it enhances HIF endothelial cells by runt-related transcrip- of this pleiotropic miRNA and would clearly stability in a novel way (see below). tion factor 1 (RUNX-1) and CCAAT/enhanc- complement its indirect, HIF-1α–dependent Among the HIF-dependent hypoxamirs er binding protein α (C/EBPα) (7). effects on angiogenesis so essential for restor- are miR210 and miR373 (7, 8). While In addition to these hypoxamir-mediated ing tissue perfusion and oxygen delivery. miR373 has not been studied in great detail responses, at least four miRNAs have been (9), miR210 has been extensively studied shown to influence HIF expression indepen- Conclusion in its role as a hypoxamir (8–13). The most dent of hypoxia. Induced by p53, miR107 Clearly, the response to hypoxia is complex robustly induced hypoxamir, miR210, is decreases expression of HIF-β (19); induced and driven by a network-based system with induced by HIF-1α (10) and suppresses by c-MYC, the miR17-92 cluster suppresses various levels of interaction and feedback. expression of the cell-cycle regulator E2F expression of HIF-1α (20); and suppressed Hypoxamirs interacting with HIF-driven transcription factor 3 (E2F3) (11), the recep- by hepatocyte growth factor, miR519c sup- responses add a combinatorial richness to tor tyrosine kinase ligand ephrin A3 (12), presses expression of HIF-1α (21). In con- and the DNA repair protein RAD52 (13). trast, miR31, by decreasing expression of the miR210 was recently also shown to have the HIF regulatory factor factor-inhibiting HIF important role of suppressing mitochondrial (FIH), increases expression of HIF-1α (22).
Load more

Recommended publications
  • Case Report a Fetus with Kabuki Syndrome 2 Detected by Chromosomal Microarray Analysis
    Int J Clin Exp Pathol 2020;13(2):302-306 www.ijcep.com /ISSN:1936-2625/IJCEP0104334 Case Report A fetus with Kabuki syndrome 2 detected by chromosomal microarray analysis Chen-Zhao Lin1, Bi-Ru Qi1, Jian-Su Hu2, Xiu-Qiong Huang3 Departments of 1Obstetrics and Gynecology, 2Ultrasound, 3Laboratory Medicine, Fuzhou Municipal First Hospital Affiliated to Fujian Medical University, Fuzhou 350009, Fujian Province, The People’s Republic of China Received November 1, 2019; Accepted January 26, 2020; Epub February 1, 2020; Published February 15, 2020 Abstract: Background: Kabuki syndrome is a rare multiple congenital anomaly syndrome characterized by distinct facial features, intellectual disability, cardiovascular and musculoskeletal abnormalities, persistence of fetal finger- tip pads, and postnatal growth deficiency. Currently, the diagnosis mainly depends on clinical manifestations and genetic testing. To date, there is no report on the identification Kabuki syndrome in fetuses using chromosomal microarray analysis (CMA). Case presentation: A fetus was identified with growth retardation and cardiovascular abnormality on color Doppler ultrasonography; however, non-invasive prenatal testing (NIPT) revealed a low risk and G-banding karyotyping revealed no abnormal karyotype detected. CMA identified a 1.3 Mb deletion on the X chromosome (Xp11.3) containing KDM6A, DUSP21, MIR222, MIR221 and CXorf36 genes. The fetus was diagnosed with Kabuki syndrome 2, and labor was induced. In addition, CMA detected a 1.3 Mb deletion in the chromosome Xp11.3 in the mother, which contains 5 genes namely KDM6A, DUSP21, MIR222, MIR221 and CXorf36, while no chromosomal abnormality was identified in the father. Conclusions: We report a fetus with Kabuki syndrome 2 detected using CMA.
    [Show full text]
  • The Role of Microrna in Human Leukemia: a Review
    Leukemia (2009) 23, 1257–1263 & 2009 Macmillan Publishers Limited All rights reserved 0887-6924/09 $32.00 www.nature.com/leu SPOTLIGHT REVIEW The role of microRNA in human leukemia: a review S Yendamuri1 and GA Calin2 1Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA and 2Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA MicroRNAs (miRNAs or miRs) are 18–22-nucleotide non-coding target. If the sequence is a perfect match, the final result seems RNAs that have emerged as a new paradigm of epigenetic to be target mRNA degradation in a manner similar to siRNA- regulation in both normal development and cellular function, and in the pathogenesis of human disease including cancer. induced gene expression silencing. This seems to be the This review summarizes the current literature of mechanism of predominant mechanism in plants. A less than perfect match gene regulation by miRNA and their role in hematopoiesis and may result in inefficient translation leading to effective down- leukemogenesis. An understanding of these processes sug- regulation of the gene, a mechanism more common in gests further avenues for research to understand gene regula- animals.7–9 Isolated examples of miRNA leading to upregulation tion and miRNA-based therapeutic approaches. of genes have been reported.10 Leukemia (2009) 23, 1257–1263; doi:10.1038/leu.2008.382; The mechanism of translational repression is known only published online 15 January 2009 11 Keywords: microRNA; non-coding RNA; microarray; partially. The mRNA segments that miRNAs bind seem to be mostly in the 30UTRs of genes.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Development of Novel Therapeutic Agents by Inhibition of Oncogenic Micrornas
    International Journal of Molecular Sciences Review Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs Dinh-Duc Nguyen and Suhwan Chang * ID Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea; [email protected] * Correspondence: [email protected] Received: 21 November 2017; Accepted: 22 December 2017; Published: 27 December 2017 Abstract: MicroRNAs (miRs, miRNAs) are regulatory small noncoding RNAs, with their roles already confirmed to be important for post-transcriptional regulation of gene expression affecting cell physiology and disease development. Upregulation of a cancer-causing miRNA, known as oncogenic miRNA, has been found in many types of cancers and, therefore, represents a potential new class of targets for therapeutic inhibition. Several strategies have been developed in recent years to inhibit oncogenic miRNAs. Among them is a direct approach that targets mature oncogenic miRNA with an antisense sequence known as antimiR, which could be an oligonucleotide or miRNA sponge. In contrast, an indirect approach is to block the biogenesis of miRNA by genome editing using the CRISPR/Cas9 system or a small molecule inhibitor. The development of these inhibitors is straightforward but involves significant scientific and therapeutic challenges that need to be resolved. In this review, we summarize recent relevant studies on the development of miRNA inhibitors against cancer. Keywords: antimiR; antagomiR; miRNA-sponge; oncomiR; CRISPR/Cas9; cancer therapeutics 1. Introduction Cancer has been the leading cause of death and a major health problem worldwide for many years; basically, it results from out-of-control cell proliferation. Traditionally, several key proteins have been identified and found to affect signaling pathways regulating cell cycle progression, apoptosis, and gene transcription in various types of cancers [1,2].
    [Show full text]
  • Differential Expression of Micrornas in Adipose Tissue After Long-Term High-Fat Diet-Induced Obesity in Mice
    Differential Expression of MicroRNAs in Adipose Tissue after Long-Term High-Fat Diet-Induced Obesity in Mice Dionysios V. Chartoumpekis1, Apostolos Zaravinos2, Panos G. Ziros1, Ralitsa P. Iskrenova1, Agathoklis I. Psyrogiannis1, Venetsana E. Kyriazopoulou1, Ioannis G. Habeos1* 1 Department of Internal Medicine, Division of Endocrinology, Medical School, University of Patras, Patras, Greece, 2 Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Greece Abstract Obesity is a major health concern worldwide which is associated with increased risk of chronic diseases such as metabolic syndrome, cardiovascular disease and cancer. The elucidation of the molecular mechanisms involved in adipogenesis and obesogenesis is of essential importance as it could lead to the identification of novel biomarkers and therapeutic targets for the development of anti-obesity drugs. MicroRNAs (miRNAs) have been shown to play regulatory roles in several biological processes. They have become a growing research field and consist of promising pharmaceutical targets in various fields such as cancer, metabolism, etc. The present study investigated the possible implication of miRNAs in adipose tissue during the development of obesity using as a model the C57BLJ6 mice fed a high-fat diet. C57BLJ6 wild type male mice were fed either a standard (SD) or a high-fat diet (HFD) for 5 months. Total RNA was prepared from white adipose tissue and was used for microRNA profiling and qPCR. Twenty-two of the most differentially expressed miRNAs, as identified by the microRNA profiling were validated using qPCR. The results of the present study confirmed previous results. The up- regulation of mmu-miR-222 and the down-regulation of mmu-miR-200b, mmu-miR-200c, mmu-miR-204, mmu-miR-30a*, mmu-miR-193, mmu-miR-378 and mmu-miR-30e* after HFD feeding has also been previously reported.
    [Show full text]
  • Supplementary Information.Pdf
    Supplementary Information Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein‐Barr virus infection Huaqing Zhong1, Xinran Hu2, Andrew B. Janowski2, Gregory A. Storch2, Liyun Su1, Lingfeng Cao1, Jinsheng Yu3, and Jin Xu1 Department of Clinical Laboratory1, Children's Hospital of Fudan University, Minhang District, Shanghai 201102, China; Departments of Pediatrics2 and Genetics3, Washington University School of Medicine, Saint Louis, Missouri 63110, United States. Supplementary information includes the following: 1. Supplementary Figure S1: Fold‐change and correlation data for hyperactive and hypoactive genes. 2. Supplementary Table S1: Clinical data and EBV lab results for 110 study subjects. 3. Supplementary Table S2: Differentially expressed genes between AIM vs. Healthy controls. 4. Supplementary Table S3: Differentially expressed genes between CAEBV vs. Healthy controls. 5. Supplementary Table S4: Fold‐change data for 303 immune mediators. 6. Supplementary Table S5: Primers used in qPCR assays. Supplementary Figure S1. Fold‐change (a) and Pearson correlation data (b) for 10 cell markers and 61 hypoactive and hyperactive genes identified in subjects with acute EBV infection (AIM) in the primary cohort. Note: 23 up‐regulated hyperactive genes were highly correlated positively with cytotoxic T cell (Tc) marker CD8A and NK cell marker CD94 (KLRD1), and 38 down‐regulated hypoactive genes were highly correlated positively with B cell, conventional dendritic cell
    [Show full text]
  • Induction of Micrornas, Mir-155, Mir-222, Mir-424 and Mir-503, Promotes Monocytic Differentiation Through Combinatorial Regulation
    Leukemia (2010) 24, 460–466 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ‘ ORIGINAL ARTICLE Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation ARR Forrest1,2, M Kanamori-Katayama1, Y Tomaru1, T Lassmann1, N Ninomiya1, Y Takahashi1, MJL de Hoon1, A Kubosaki1, A Kaiho1, M Suzuki1, J Yasuda1, J Kawai1, Y Hayashizaki1, DA Hume3 and H Suzuki1 1LSA Technology Development Unit, Omics Science Center, RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan; 2The Eskitis Institute for Cell and Molecular Therapies, Griffith University, Brisbane, Queensland, Australia and 3The Roslin Institute, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, UK Acute myeloid leukemia (AML) involves a block in terminal that might promote differentiation. MicroRNAs are short 21–22 differentiation of the myeloid lineage and uncontrolled prolif- nucleotide RNA molecules that cause translational repression eration of a progenitor state. Using phorbol myristate acetate and degradation of multiple mRNAs by binding target sequences (PMA), it is possible to overcome this block in THP-1 cells 0 5 (an M5-AML containing the MLL-MLLT3 fusion), resulting in in their 3 UTRs. Multiple microRNAs are implicated in differentiation to an adherent monocytic phenotype. As part of differentiation of cell lineages including skeletal muscle, FANTOM4, we used microarrays to identify 23 microRNAs that adipocytes and neurons6–8 and in mammals, the microRNA are regulated by PMA. We identify four PMA-induced micro- subsystem is essential for embryonic development. Dicer RNAs (mir-155, mir-222, mir-424 and mir-503) that when over- is required for differentiation of embryonic stem cells,9 Dicer expressed cause cell-cycle arrest and partial differentiation and (À/À) knockouts are embryonic lethal10 and Ago2 (À/À) when used in combination induce additional changes not seen 11 by any individual microRNA.
    [Show full text]
  • Noncoding Rnas As Novel Pancreatic Cancer Targets
    NONCODING RNAS AS NOVEL PANCREATIC CANCER TARGETS by Amy Makler A Thesis Submitted to the Faculty of The Charles E. Schmidt College of Science In Partial Fulfillment of the Requirements for the Degree of Master of Science Florida Atlantic University Boca Raton, FL August 2018 Copyright 2018 by Amy Makler ii ACKNOWLEDGEMENTS I would first like to thank Dr. Narayanan for his continuous support, constant encouragement, and his gentle, but sometimes critical, guidance throughout the past two years of my master’s education. His faith in my abilities and his belief in my future success ensured I continue down this path of research. Working in Dr. Narayanan’s lab has truly been an unforgettable experience as well as a critical step in my future endeavors. I would also like to extend my gratitude to my committee members, Dr. Binninger and Dr. Jia, for their support and suggestions regarding my thesis. Their recommendations added a fresh perspective that enriched our initial hypothesis. They have been indispensable as members of my committee, and I thank them for their contributions. My parents have been integral to my successes in life and their support throughout my education has been crucial. They taught me to push through difficulties and encouraged me to pursue my interests. Thank you, mom and dad! I would like to thank my boyfriend, Joshua Disatham, for his assistance in ensuring my writing maintained a logical progression and flow as well as his unwavering support. He was my rock when the stress grew unbearable and his encouraging words kept me pushing along.
    [Show full text]
  • Expression and Change of Mirs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan Or Olmesartan
    biomedicines Article Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan Giuseppe Mandraffino 1,2,3,*,† , Alberto Lo Gullo 4,*,† , Maria Cinquegrani 1, Angela D’Ascola 3, Davide Sinicropi 1, Egidio Imbalzano 1 , Giuseppe Blando 1, Giuseppe Maurizio Campo 3, Carmela Morace 1, Clemente Giuffrida 4, Salvatore Campo 5, Giovanni Squadrito 1,‡ and Michele Scuruchi 2,3,‡ 1 Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; [email protected] (M.C.); [email protected] (D.S.); [email protected] (E.I.); [email protected] (G.B.); [email protected] (C.M.); [email protected] (G.S.) 2 Lipid Center, Internal Medicine Unit, University of Messina, 98122 Messina, Italy; [email protected] 3 Laboratory of Clinical Biochemistry, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; [email protected] (A.D.); [email protected] (G.M.C.) 4 IRCCS Neurolesi Bonino Pulejo, 98123 Messina, Italy; [email protected] 5 Laboratory of Molecular Biology, Department of Biomedical and Dental Sciences and Morphofunctional Images, University of Messina, 98122 Messina, Italy; [email protected] * Correspondence: gmandraffi[email protected] (G.M.); [email protected] (A.L.G.) † These authors equally contributed to this work: co-first authors. ‡ These authors equally contributed to this work: both senior authors. Citation: Mandraffino, G.; Lo Gullo, Abstract: miR profile could be associated to CV risk, and also to prognosis/outcome in response to A.; Cinquegrani, M.; D’Ascola, A.; Sinicropi, D.; Imbalzano, E.; Blando, therapeutic approach. We aimed to evaluate if anti-hypertensive drugs enalapril, losartan or olmesar- G.; Campo, G.M.; Morace, C.; tan have effects on monocyte miR profile in essential hypertensives without target organ involvement.
    [Show full text]
  • Dynamic and Modularized Microrna Regulation and Its Implication in Human Cancers
    www.nature.com/scientificreports OPEN Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers Received: 8 February 2017 Jiang Shu1, Bruno Vieira Resende e Silva1, Tian Gao1, Zheng Xu2,3 & Juan Cui1 Accepted: 26 September 2017 MicroRNA is responsible for the fne-tuning of fundamental cellular activities and human disease Published: xx xx xxxx development. The altered availability of microRNAs, target mRNAs, and other types of endogenous RNAs competing for microRNA interactions refects the dynamic and conditional property of microRNA- mediated gene regulation that remains under-investigated. Here we propose a new integrative method to study this dynamic process by considering both competing and cooperative mechanisms and identifying functional modules where diferent microRNAs co-regulate the same functional process. Specifcally, a new pipeline was built based on a meta-Lasso regression model and the proof-of-concept study was performed using a large-scale genomic dataset from ~4,200 patients with 9 cancer types. In the analysis, 10,726 microRNA-mRNA interactions were identifed to be associated with a specifc stage and/or type of cancer, which demonstrated the dynamic and conditional miRNA regulation during cancer progression. On the other hands, we detected 4,134 regulatory modules that exhibit high fdelity of microRNA function through selective microRNA-mRNA binding and modulation. For example, miR-18a-3p, −320a, −193b-3p, and −92b-3p co-regulate the glycolysis/gluconeogenesis and focal adhesion in cancers of kidney, liver, lung, and uterus. Furthermore, several new insights into dynamic microRNA regulation in cancers have been discovered in this study. Mature microRNAs (miRNAs) are typically 20–25 nucleotides long.
    [Show full text]
  • Inhibition of Mir-222 by Oncolytic Adenovirus-Encoded Mirna Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models
    cancers Article Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models Giulia Raimondi 1, Sabrina Gea-Sorlí 1,2, Marc Otero-Mateo 1 and Cristina Fillat 1,2,3,* 1 Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; [email protected] (G.R.); [email protected] (S.G.-S.); [email protected] (M.O.-M.) 2 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 08036 Barcelona, Spain 3 Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), 08036 Barcelona, Spain * Correspondence: cfi[email protected] Simple Summary: Oncolytic adenoviruses are replication-competent viruses engineered for use in cancer treatment. However, the transformation of cancer cells defines a scenario in which the viruses are not adapted to replicate. During tumorigenesis, a large number of miRNAs are deregulated, modulating the expression of genes with essential roles in carcinogenesis and with potential effects on adenoviral propagation. Here we show how OncomiRs can impact adenoviral activity, identifying miR-222 as a limiting factor. Of notice, by genetically engineering a therapeutic adenovirus with miR-222 sponges (AdNuPAR-E-miR222-S), we reduced the latter miRNA content, while enhancing adenoviral fitness, increasing cytotoxicity, and sustaining tumor growth control in xenografts. Citation: Raimondi, G.; Gea-Sorlí, S.; Abstract: Oncolytic adenoviruses (OA) are envisioned as a therapeutic option for patients with cancer, Otero-Mateo, M.; Fillat, C. Inhibition designed to preferentially replicate in cancer cells. However, the high number of genetic alterations in of miR-222 by Oncolytic tumors can generate a context in which adenoviruses have difficulties replicating.
    [Show full text]
  • Distinct Requirements of Micrornas in NK Cell Activation, Survival, and Function
    The Journal of Immunology Distinct Requirements of MicroRNAs in NK Cell Activation, Survival, and Function Natalie A. Bezman,*,† Elizabeth Cedars,*,†,‡ David F. Steiner,*,†,‡ Robert Blelloch,x,{ David G. T. Hesslein,*,† and Lewis L. Lanier*,†,‡ MicroRNAs (miRNAs) are small noncoding RNAs that have recently emerged as critical regulators of gene expression within the immune system. In this study, we used mice with conditional deletion of Dicer and DiGeorge syndrome critical region 8 (Dgcr8) to dissect the roles of miRNAs in NK cell activation, survival, and function during viral infection. We developed a system for deletion of either Dicer or Dgcr8 in peripheral NK cells via drug-induced Cre activity. We found that Dicer- and Dgcr8-deficient NK cells were significantly impaired in survival and turnover, and had impaired function of the ITAM-containing activating NK cell receptors. We further demonstrated that both Dicer- and Dgcr8-dependent pathways were indispensable for the expansion of Ly49H+ NK cells during mouse cytomegalovirus infection. Our data indicate similar phenotypes for Dicer- and Dgcr8-deficient NK cells, which strongly suggest that these processes are regulated by miRNAs. Thus, our findings indicate a critical role for miRNAs in controlling NK cell homeostasis and effector function, with implications for miRNAs regulating diverse aspects of NK cell biology. The Journal of Immunology, 2010, 185: 3835–3846. atural killer cells are a key component of the innate im- complexes results in recruitment and activation of protein tyrosine mune system, providing early cellular defense against kinases, which initiate the signaling cascade, resulting in secretion N viruses and intracellular pathogens, and contributing to of effector cytokines, such as IFN-g, and target cell cytotoxicity.
    [Show full text]